Nacka, Sweden

Andreas Svennebring


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Svennebring

Introduction

Andreas Svennebring is a notable inventor based in Nacka, Sweden. He has made significant contributions to the field of pharmacology, particularly in the development of selective receptor agonists. With a total of 2 patents, his work focuses on addressing critical health issues such as obesity and psychiatric disorders.

Latest Patents

Svennebring's latest patents include highly selective 5-HT(2C) receptor agonists that exhibit anti-psychotic effects while also demonstrating antagonist activity at the 5-HT(2B) receptor. These agonists are designed for use in treating diseases and conditions where modulation of 5-HT(2C) receptors can provide therapeutic benefits. His innovative approach aims to enhance treatment options for patients suffering from various psychiatric conditions.

Career Highlights

Throughout his career, Svennebring has worked with prestigious institutions, including the University of Illinois and the University of North Carolina at Chapel Hill. His research has contributed to the understanding and development of new therapeutic agents that target specific receptors in the brain.

Collaborations

Some of his notable collaborators include Alan P. Kozikowski and Bryan Leo Roth. Their combined expertise has further advanced the research and development of innovative pharmacological solutions.

Conclusion

Andreas Svennebring's work exemplifies the impact of innovative research in the field of pharmacology. His contributions through selective receptor agonists are paving the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…